Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation: Results From ROCKET AF (Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atr
about
Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation: Results From ROCKET AF (Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atr
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Noncentral Nervous System Syst ...... roke and Embolism Trial in Atr
@en
Noncentral Nervous System Syst ...... roke and Embolism Trial in Atr
@nl
type
label
Noncentral Nervous System Syst ...... roke and Embolism Trial in Atr
@en
Noncentral Nervous System Syst ...... roke and Embolism Trial in Atr
@nl
prefLabel
Noncentral Nervous System Syst ...... roke and Embolism Trial in Atr
@en
Noncentral Nervous System Syst ...... roke and Embolism Trial in Atr
@nl
P2093
P2860
P50
P1476
Noncentral Nervous System Syst ...... roke and Embolism Trial in Atr
@en
P2093
Daniel E Singer
Daniel Wojdyla
David Huberman
Keith A A Fox
Manesh R Patel
Ryan Orgel
W Schuyler Jones
P2860
P356
10.1161/CIRCOUTCOMES.116.003520
P577
2017-05-01T00:00:00Z